Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Areas At Risk For Locally Acquired Vector-borne Zika Cases

Zika virus information for the blood and tissue collection community

CDC is working with state health departments and blood and tissue collection organizations to help ensure the safety of our blood and tissue supply and reduce the risk of Zika virus transmission through blood transfusions and tissue transplants. Zika virus disease is a nationally notifiable condition. Cases are reported to CDC by state and local health departments using standard case definitions.

Special Notice – March 13, 2017

Potential Increased Risk to Blood and Tissue Safety

CDC has identified the potential for increased risk to blood and tissue safety in Miami-Dade County starting on June 15, 2016. The potential risk in Miami-Dade County did not meet the threshold for designation as an area of active transmission until July 29, 2016. CDC has also identified that since June 15, 2016, there has been a potential increased risk to blood and tissue safety in Broward and Palm Beach counties because of local travel of residents of these counties to areas of active transmission in Florida. The complete list of current and past areas of active transmission is provided below.

Guidance for Healthcare Providers Caring for Pregnant Women

FDA: 2017 Safety and Availability Communications

Areas of Active Transmission in the United States

To protect the US blood and tissue supply, CDC in collaboration with the US Food and Drug Administration (FDA) defines areas of active Zika virus transmission as having two or more locally acquired cases of Zika virus infection within 45 days. These defined areas of risk can be different from areas for which CDC has issued travel guidance because of concerns about potential risk for blood and tissue safety.

The following are areas of active transmission of Zika virus in the continental United States for the purpose of blood and tissue safety intervention:

The following are previously listed areas of active transmission of Zika virus in the continental United States for the purpose of blood and tissue safety intervention:

*No new cases of local Zika virus transmission have been identified for a period of 45-days.  

Travel notice posting dates for countries and territories with reported local mosquito transmission of Zika virus.

Country or Territory Date Travel Notification Posted
American Samoa 2/1/2016
Angola 3/10/2017
Anguilla 6/29/2016
Antigua & Barbuda 8/3/2016
Argentina 5/26/2016
Aruba 2/18/2016
Bahamas 8/23/2016
Barbados 1/26/2016
Belize 4/18/2016
Bolivia 1/22/2016
Bonaire 2/18/2016
Brazil 6/9/2015
British Virgin Islands 8/30/16
Cape Verde 1/26/2016
Cayman Islands 8/11/2016
Colombia 12/10/2015
Costa Rica 2/1/2016
Cuba 3/19/2016
Curacao 2/1/2016
Dominica 3/19/2016
Ecuador 1/22/2016
El Salvador 12/10/2015
Fiji 4/4/2016
French Guiana 12/18/2015
Grenada 5/12/2016
Guadeloupe 1/26/2016
Guatemala 12/10/2015
Guinea-Bissau 3/10/2017
Guyana 1/22/2016
Haiti 1/26/2016
Honduras 2/1/2016
Jamaica 2/3/2016
Kosrae (FSM) 4/1/2016
Maldives 3/10/2017
Marshall Islands 2/23/2016
Martinique 1/26/2016
Mexico 12/10/2015
Montserrat 11/21/16
New Caledonia 3/9/2016
Nicaragua 2/1/2016
Palau 11/16/2016
Panama 12/10/2015
Papua New Guinea 4/29/2016
Paraguay 12/10/2015
Peru 5/5/2016
Puerto Rico 12/31/2015
Saba 7/26/2016
Saint Bartelemy 5/9/2016
Saint Lucia 4/11/2016
Saint Martin 1/26/2016
Samoa 2/1/2016
Singapore 8/30/16
Sint Eustatius 7/14/2016
Sint Maarten 2/29/2016
Solomon Islands 3/10/2017
St. Vincent & the Grenadines 2/29/2016
St. Kitts and Nevis 9/26/2016
Suriname 11/12/2015
The Dominican Republic 1/26/2016
Tonga 2/3/2016
Trinidad & Tobago 2/23/2016
Turks & Caicos 8/3/2016
US Virgin Islands 1/26/2016
Venezuela 12/10/2015